HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of Brimonidine and Timolol on the Progression of Visual Field Defects in Open-angle Glaucoma: A Single-center Randomized Trial.

Abstract
PRéCIS:: Instillation of brimonidine or timolol slowed visual field deterioration in patients with open-angle glaucoma; both brimonidine and timolol might improve the mean deviation (MD) slopes.
PURPOSE:
The purpose of this study was to investigate and compare the effects of 0.1% brimonidine and 0.5% timolol on the progressing visual field defects in open-angle glaucoma.
PATIENTS AND METHODS:
We evaluated 1 eye each of 68 glaucoma patients who were treated with at least 1 prostaglandin analog. Their baseline MD slopes were < -0.5 dB/y based on at least 5 Humphrey field analyzer measurements within 3 years. Eligible eyes were randomly assigned to brimonidine or timolol treatment groups and treatments were administered without the wash-out period. Clinical examinations were performed every 4 months for 2 years. We designated the MD slope as the primary endpoint.
RESULTS:
Ultimately, 56 eyes (brimonidine:timolol=26:30) were included in the present study (mean age=65.2 y). Dropout rates of brimonidine and timolol treatment groups were 27.8% and 6.3%, respectively. There were no significant differences in baseline intraocular pressure or MD slopes between brimonidine and timolol groups (12.7 and 12.9 mm Hg, P=0.77, and -1.22 and -1.08 dB/y, P=0.43, respectively). Intraocular pressure decreased significantly in the brimonidine group at 4, 8, 12, and 16 months, and in the timolol group at 4 months, without significant differences between the drugs (P=0.20). MD slopes significantly improved in both groups (brimonidine: -0.38 dB/y, P<0.001; timolol: -0.52 dB/y, P=0.04). Furthermore, there was no significant difference between groups in the primary endpoint (P=0.59).
CONCLUSION:
Brimonidine and timolol treatments improved MD slopes in open-angle glaucoma.
AuthorsYu Yokoyama, Ryo Kawasaki, Hidetoshi Takahashi, Shigeto Maekawa, Satoru Tsuda, Kazuko Omodaka, Toru Nakazawa
JournalJournal of glaucoma (J Glaucoma) Vol. 28 Issue 7 Pg. 575-583 (07 2019) ISSN: 1536-481X [Electronic] United States
PMID31188229 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Antihypertensive Agents
  • Brimonidine Tartrate
  • Timolol
Topics
  • Aged
  • Antihypertensive Agents (therapeutic use)
  • Brimonidine Tartrate (therapeutic use)
  • Disease Progression
  • Double-Blind Method
  • Female
  • Glaucoma, Open-Angle (diagnosis, drug therapy, physiopathology)
  • Humans
  • Intraocular Pressure (drug effects)
  • Male
  • Middle Aged
  • Prospective Studies
  • Timolol (therapeutic use)
  • Tonometry, Ocular
  • Vision Disorders (diagnosis, drug therapy, physiopathology)
  • Visual Field Tests
  • Visual Fields (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: